Evaluate

March 13, 2019

Smith & Nephew buys Osiris and insists it has appetite for more

The UK ortho and woundcare group might yet pounce on Nuvasive.

November 24, 2017

Upcoming events – Another SGLT2 approval due and stem cell data for Mesoblast

March 30, 2015

Stryker and Osiris step into the bony void

August 14, 2013

Stem cells get a win as Osiris's Grafix impresses in diabetic foot ulcers

August 09, 2013

Teplizumab surprise puts spotlight on type 1 diabetes antibodies

January 24, 2013

Liftoff for 2012’s big drug hopes

November 15, 2012

Marqibo and Vascepa join Vitaros in biotech purgatory

July 20, 2012

Key data readouts in the second half of 2012

May 24, 2012

Stem cell therapies needing more regulatory acceptance